Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Ashfield Healthcare expands its board of directors

Seven new members join the board

Eli Lilly HQ

Lilly wins European approval for lung cancer drug Portrazza

First biologic licenced in EU as a first-line treatment for adults with NSCLC

- PMLiVE

Pharma forms Parkinson’s disease trials consortium

Hopes to make clinical trials “smarter” through sharing of past PD trial data

- PMLiVE

Breaking Down the Barriers to Behaviour Change by Patrick Ladbury

Patrick Ladbury, the Director at the NSMC delves further into the barriers to behaviour change, and offers us tricks of the trade in his second instalment.

Say Communications

Novo Nordisk adds to board of directors

Brian Daniels elected to join the board

- PMLiVE

The leadership challenge

How smaller pharma firms can contend with the major players

NDA Group appoints Bill Griffiths as general manager, UK

He also becomes vice president of the consultancy's advisory board

- PMLiVE

Virtual reality

How gaming apps are being used in healthcare to improve patient adherence and quality of life

Affiliate friendly content: e-detailing materials that local markets love

What’s the point of marketing content that doesn’t get used?

Anthill Agency

- PMLiVE

Death by Numbers

The iconic ads that could have been

- PMLiVE

Searching for health

Janssen France’s Emmanuelle Quiles on finding ways to produce pharma innovations in a challenging environment

Bayer symbol

Bayer gets first approval for Kogenate upgrade Kovaltry

First worldwide licence for the haemophilia treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links